XSC
DCOY

X-Square Capital’s Decoy Therapeutics DCOY Stock Holding History

X-Square Capital’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$17K – 157
2022
Q3 		$17K Hold
2
– – 0.01% 146
2022
Q2 		$19K Sell
2
-1
-33% -$8.63K 0.01% 152
2022
Q1 		$39K Hold
3
– – 0.02% 150
2021
Q4 		$48K Hold
3
– – 0.02% 146
2021
Q3 		$103K Hold
3
– – 0.05% 150
2021
Q2 		$106K Sell
3
-2
-40% -$89K 0.05% 134
2021
Q1 		$245K Buy
5
+3
+150% +$172K 0.11% 106
2020
Q4 		$53K Buy
+2
New +$58.6K 0.03% 105

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

X-Square Capital's DCOY Position: Q4 2022 in Review

X-Square Capital sold out of Decoy Therapeutics (DCOY) in Q4 2022, closing a stake of 2 shares — an estimated $17K sold.

X-Square Capital first reported a position in DCOY in Q4 2020 and held it in 8 quarters. The position peaked at $245K in Q1 2021. 4 funds tracked by Wall St. Rank hold DCOY as of Q4 2022.

  • X-Square Capital reported no remaining Decoy Therapeutics position as of Q4 2022 after selling out during the quarter.
  • X-Square Capital sold 2 Decoy Therapeutics shares in Q4 2022, an estimated $17K.
  • X-Square Capital first reported a position in Decoy Therapeutics in Q4 2020 and held it in 8 quarters.
  • X-Square Capital's Decoy Therapeutics position peaked at $245K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Decoy Therapeutics as of Q4 2022.

Based on X-Square Capital's 13F filing for Q4 2022, filed 2 Feb 2023.